Article metrics

Download PDFPDF

Original research
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial

 

Online download statistics by month:

Online download statistics by month: May 2020 to August 2020

AbstractFullPdf
May 2020313313140
Jun 202015315354
Jul 2020696937
Aug 2020615919
Total596594250